See what’s changing first. Know which accounts matter next.
Fundz catches funding rounds before they’re announced, and acquisitions, new executives, hiring shifts and contract wins as they happen. It weighs them against your ideal customer profile and delivers a ranked shortlist every morning, with the evidence, the reason to reach out and the decision maker to contact. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
Xilio Therapeutics Appoints Yariv Houvras as Chief Medical Officer
PRIVATESep 28, 2026
Position
Chief Medical Officer
Company
Xilio Therapeutics
Yariv Houvras
United StatesBiotechnologyHealth CareTherapeutics
Description
Xilio Therapeutics has appointed Yariv Houvras as Chief Medical Officer. This move will support the company's advancement of its bispecific PD-1/masked IL-2 candidate, XTX501.
Company Information
Company
Xilio Therapeutics
Location
United States
About
Xilio Therapeutics is a US biotech company focused on developing masked immuno-oncology therapies. The company aims to advance novel treatments through innovative clinical development. It specializes in transformational therapies for cancer, leveraging cutting-edge science to target immune responses.
Fundz sees it the moment Xilio Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.